1. Home
  2. RDW vs BCRX Comparison

RDW vs BCRX Comparison

Compare RDW & BCRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

RDW

Redwire Corporation

HOLD

Current Price

$9.72

Market Cap

2.1B

Sector

Industrials

ML Signal

HOLD

Logo BioCryst Pharmaceuticals Inc.

BCRX

BioCryst Pharmaceuticals Inc.

HOLD

Current Price

$8.84

Market Cap

2.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RDW
BCRX
Founded
2020
1986
Country
United States
United States
Employees
1410
N/A
Industry
Military/Government/Technical
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.1B
2.4B
IPO Year
N/A
1995

Fundamental Metrics

Financial Performance
Metric
RDW
BCRX
Price
$9.72
$8.84
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
8
11
Target Price
$13.71
$20.82
AVG Volume (30 Days)
14.0M
3.7M
Earning Date
05-08-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
381.40
EPS
N/A
N/A
Revenue
N/A
$25,186,000.00
Revenue This Year
$41.68
N/A
Revenue Next Year
$20.25
$12.55
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$4.87
$6.00
52 Week High
$26.64
$11.22

Technical Indicators

Market Signals
Indicator
RDW
BCRX
Relative Strength Index (RSI) 45.90 39.73
Support Level $7.87 $8.80
Resistance Level $10.43 $9.31
Average True Range (ATR) 0.74 0.34
MACD 0.21 -0.10
Stochastic Oscillator 68.11 3.60

Price Performance

Historical Comparison
RDW
BCRX

About RDW Redwire Corporation

Redwire Corp is an integrated space and defense technology company focused on technologies including aerospace infrastructure, autonomous systems and multi-domain operations, leveraging digital engineering and artificial intelligence automation. The Company develops and provides mission critical solutions based on space and defense technology platform offerings for government, commercial and civil customers through both short- and long-duration projects. These include technologies and production capability for next-generation spacecraft, large space infrastructure, microgravity capabilities, combat autonomous systems, optical sensors and radio frequency payloads that provide intelligence, surveillance, and reconnaissance capabilities for U.S. and allied nations across multiple domains.

About BCRX BioCryst Pharmaceuticals Inc.

BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, to block key enzymes involved in infectious and inflammatory diseases. Biocryst's research is based on multiple scientific disciplines like biology, computer modeling, and medicinal chemistry. Its products and candidates target the following therapeutic areas: acute uncomplicated influenza; uncomplicated seasonal influenza; hereditary angioedema; filoviruses, including the Ebola and Marburg viruses; and oncology.

Share on Social Networks: